Corrupt relationships between drug companies and medical providers seem to be on the upswing – and that's saying a lot. When kickbacks of various sorts contaminate what is supposed to be the independent medical judgment of a doctor or other provider, patients are put at risk. Companies that play by the rules are punished by the market, and distrust of the medical profession increases. The False Claims Act and the Anti-Kickback Statute play essential roles in helping whistleblowers bring these types of fraud to light. — Shayne Stevenson, Head of Whistleblower Practice